Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error page, with the site header and footer visible, indicating restricted access to the content.
    Difference
    18%
    Check dated 2026-09-19T22:20:29.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now reflects a new site revision (v3.6.6) replacing the previous version (v3.6.5). This appears to be a minor maintenance/update to the site interface and does not affect the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:16:37.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4, as a software version update. It does not modify the study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T16:53:56.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The revision label on the page has been updated from v3.6.3 to v3.6.4, indicating a small underlying update to the site. The visible study details and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T08:21:51.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T22:46:31.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page now shows an updated Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor platform update to the study details page.
    Difference
    0.1%
    Check dated 2026-06-26T23:19:16.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.